MKI67 and breast carcinoma: Immunohistochemistry analysis of xenografts tissue sections revelead a significant increased Ki67 value in tumors generated by co-injection of ASCs with KBr1 (40%) or with KBr2 (30%) in comparison with control tumors which showed the same value of primary breast cancer tissues (20% and 10% respectively) (Figure 2D and E).